person

Idoia M. R.

Country
Spain
Department
7007: Oncologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 33 partner sites.

Specializations

Neuro-Oncology Focus

This investigator specializes in treating patients with WHO Grade IV glioblastoma, particularly focusing on post-surgical therapeutic interventions for newly diagnosed cases. Their research encompasses treatment approaches for patients who have undergone complete or partial tumor resection.

  • Primary brain tumors
  • Post-surgical therapy
  • Advanced glioblastoma management

Their work involves exploring novel therapeutic combinations for improving outcomes in brain cancer patients.

Solid Tumor Research

The investigator conducts research in the treatment of various solid tumors, with particular attention to combination therapy approaches. Their expertise includes evaluating novel therapeutic combinations with anticancer drugs to enhance treatment efficacy.

  • Combination therapy development
  • Treatment response assessment
  • Novel therapeutic strategies

Their research focuses on establishing optimal treatment protocols and assessing objective response rates in solid tumor patients.

Treatment Innovation

The investigator specializes in evaluating experimental therapeutic agents and their integration into established treatment protocols. Their work encompasses the development of innovative priming regimens for cancer therapy.

  • Drug safety evaluation
  • Treatment optimization
  • Clinical efficacy assessment

Their research aims to advance therapeutic options through careful evaluation of drug combinations and treatment sequences.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.